202 related articles for article (PubMed ID: 30252057)
1. Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men.
Wu S; Yuen F; Swerdloff RS; Pak Y; Thirumalai A; Liu PY; Amory JK; Bai F; Hull L; Blithe DL; Anawalt BD; Parman T; Kim K; Lee MS; Bremner WJ; Page ST; Wang C
J Clin Endocrinol Metab; 2019 Mar; 104(3):629-638. PubMed ID: 30252057
[TBL] [Abstract][Full Text] [Related]
2. Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy Men.
Yuen F; Thirumalai A; Pham C; Swerdloff RS; Anawalt BD; Liu PY; Amory JK; Bremner WJ; Dart C; Wu H; Hull L; Blithe DL; Long J; Wang C; Page ST
J Clin Endocrinol Metab; 2020 Mar; 105(3):e835-47. PubMed ID: 31976519
[TBL] [Abstract][Full Text] [Related]
3. Comparison of metabolic effects of the progestational androgens dimethandrolone undecanoate and 11β-MNTDC in healthy men.
Yuen F; Thirumalai A; Fernando FA; Swerdloff RS; Liu PY; Pak Y; Hull L; Bross R; Blithe DL; Long JE; Page ST; Wang C
Andrology; 2021 Sep; 9(5):1526-1539. PubMed ID: 33908182
[TBL] [Abstract][Full Text] [Related]
4. Acceptability of the oral hormonal male contraceptive prototype, 11β-methyl-19-nortestosterone dodecylcarbonate (11β-MNTDC), in a 28-day placebo-controlled trial.
Nguyen BT; Yuen F; Farrant M; Thirumalai A; Fernando F; Amory JK; Swerdloff RS; Anawalt BD; Blithe DL; Long JE; Liu PY; Page ST; Wang C
Contraception; 2021 Nov; 104(5):531-537. PubMed ID: 34153318
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the single dose pharmacokinetics, pharmacodynamics, and safety of two novel oral formulations of dimethandrolone undecanoate (DMAU): a potential oral, male contraceptive.
Ayoub R; Page ST; Swerdloff RS; Liu PY; Amory JK; Leung A; Hull L; Blithe D; Christy A; Chao JH; Bremner WJ; Wang C
Andrology; 2017 Mar; 5(2):278-285. PubMed ID: 27907978
[TBL] [Abstract][Full Text] [Related]
6. Effects of 28 Days of Oral Dimethandrolone Undecanoate in Healthy Men: A Prototype Male Pill.
Thirumalai A; Ceponis J; Amory JK; Swerdloff R; Surampudi V; Liu PY; Bremner WJ; Harvey E; Blithe DL; Lee MS; Hull L; Wang C; Page ST
J Clin Endocrinol Metab; 2019 Feb; 104(2):423-432. PubMed ID: 30252061
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of dimethandrolone 17β-undecanoate and 11β-methyl-19-nortestosterone 17β-dodecylcarbonate on body composition, bone mineral density, serum gonadotropins, and androgenic/anabolic activity in castrated male rats.
Attardi BJ; Marck BT; Matsumoto AM; Koduri S; Hild SA
J Androl; 2011; 32(2):183-92. PubMed ID: 20798389
[TBL] [Abstract][Full Text] [Related]
8. Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptive.
Surampudi P; Page ST; Swerdloff RS; Nya-Ngatchou JJ; Liu PY; Amory JK; Leung A; Hull L; Blithe DL; Woo J; Bremner WJ; Wang C
Andrology; 2014 Jul; 2(4):579-587. PubMed ID: 24789057
[TBL] [Abstract][Full Text] [Related]
9. The potent synthetic androgens, dimethandrolone (7α,11β-dimethyl-19-nortestosterone) and 11β-methyl-19-nortestosterone, do not require 5α-reduction to exert their maximal androgenic effects.
Attardi BJ; Hild SA; Koduri S; Pham T; Pessaint L; Engbring J; Till B; Gropp D; Semon A; Reel JR
J Steroid Biochem Mol Biol; 2010 Oct; 122(4):212-8. PubMed ID: 20599615
[TBL] [Abstract][Full Text] [Related]
10. Dimethandrolone (7alpha,11beta-dimethyl-19-nortestosterone) and 11beta-methyl-19-nortestosterone are not converted to aromatic A-ring products in the presence of recombinant human aromatase.
Attardi BJ; Pham TC; Radler LC; Burgenson J; Hild SA; Reel JR
J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):214-22. PubMed ID: 18555683
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 7α-methyl-19-nortestosterone effectiveness alone or combined with progestins on androgen receptor mediated-transactivation.
García-Becerra R; Ordaz-Rosado D; Noé G; Chávez B; Cooney AJ; Larrea F
Reproduction; 2012 Feb; 143(2):211-9. PubMed ID: 22065861
[TBL] [Abstract][Full Text] [Related]
12. 7alpha,11beta-Dimethyl-19-nortestosterone: a potent and selective androgen response modulator with prostate-sparing properties.
Cook CE; Kepler JA
Bioorg Med Chem Lett; 2005 Feb; 15(4):1213-6. PubMed ID: 15686944
[TBL] [Abstract][Full Text] [Related]
13. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
14. Effects of synthetic androgens on liver function using the rabbit as a model.
Hild SA; Attardi BJ; Koduri S; Till BA; Reel JR
J Androl; 2010; 31(5):472-81. PubMed ID: 20378929
[TBL] [Abstract][Full Text] [Related]
15. A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men.
von Eckardstein S; Noe G; Brache V; Nieschlag E; Croxatto H; Alvarez F; Moo-Young A; Sivin I; Kumar N; Small M; Sundaram K;
J Clin Endocrinol Metab; 2003 Nov; 88(11):5232-9. PubMed ID: 14602755
[TBL] [Abstract][Full Text] [Related]
16. Dimethandrolone undecanoate: a new potent orally active androgen with progestational activity.
Attardi BJ; Hild SA; Reel JR
Endocrinology; 2006 Jun; 147(6):3016-26. PubMed ID: 16497801
[TBL] [Abstract][Full Text] [Related]
17. Dimethandrolone Undecanoate, a Novel, Nonaromatizable Androgen, Increases P1NP in Healthy Men Over 28 Days.
Thirumalai A; Yuen F; Amory JK; Hoofnagle AN; Swerdloff RS; Liu PY; Long JE; Blithe DL; Wang C; Page ST
J Clin Endocrinol Metab; 2021 Jan; 106(1):e171-e181. PubMed ID: 33090208
[TBL] [Abstract][Full Text] [Related]
18. 7 alpha-methyl-nortestosterone (MENT): the optimal androgen for male contraception.
Sundaram K; Kumar N; Bardin CW
Ann Med; 1993 Apr; 25(2):199-205. PubMed ID: 8489761
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, Safety, and Tolerability of Single Oral Doses of a Novel Oxytocin Receptor Antagonist-Cligosiban-in Development for Premature Ejaculation: Three Randomized Clinical Trials in Healthy Subjects.
Osterloh IH; Muirhead GJ; Sultana S; Whaley S; van den Berg F; Atiee G
J Sex Med; 2018 Nov; 15(11):1547-1557. PubMed ID: 30341006
[TBL] [Abstract][Full Text] [Related]
20. The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.
Basaria S; Collins L; Dillon EL; Orwoll K; Storer TW; Miciek R; Ulloor J; Zhang A; Eder R; Zientek H; Gordon G; Kazmi S; Sheffield-Moore M; Bhasin S
J Gerontol A Biol Sci Med Sci; 2013 Jan; 68(1):87-95. PubMed ID: 22459616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
